Rep. Smithee introduces bill to transfer management of PPHM
A new bill filed in the Texas Legislature seeks to transfer management of the Panhandle-Plains Historical Museum (PPHM) in Canyon from West Texas A&M University to the Texas Historical Commission (THC), aiming to strengthen preservation and operation of one of the state's key cultural institutions.
Filed as an amendment to the Texas Government Code, HB 5554, introduced by State Rep. John Smithee (R-Amarillo), would authorize the THC to contract with the Panhandle-Plains Historical Society, which owns the museum's collection, for day-to-day management. The bill also allows the THC to enter into agreements with West Texas A&M University or The Texas A&M University System for the maintenance, renovation, and expansion of the museum facilities on the university's campus.
A key provision of the bill is the establishment of the Panhandle-Plains Historical Museum Fund, a dedicated source of funding outside the state treasury. This fund would be supported through admissions, gift shop sales, and donations, allowing the THC to use the funds for operational expenses, repairs, and growth without the need for legislative approval.
If the bill is passed, museum staff currently employed by West Texas A&M would transition to the THC by Sept. 1, 2025. For the bill to take effect immediately, it must pass with a two-thirds majority vote in both the Texas House and Senate. Otherwise, it would go into effect on the specified date.
The bill is aimed at securing the future of the Panhandle-Plains Historical Museum, ensuring it remains a vital part of Texas' cultural heritage. Supporters of the measure argue that transferring management to the Texas Historical Commission would provide the focused expertise needed to preserve the museum's collection and address its long-term operational needs.
This legislative effort follows the recent closure of the museum after a State Fire Marshal report highlighted critical fire and life safety concerns. According to West Texas A&M, the museum shut its doors indefinitely to address issues such as sprinkler system deficiencies, dead-end hallways, and inadequate exits. The total cost of the required renovations is estimated at nearly $100 million.
State Sen. Kevin Sparks (R-Midland) has filed an identical companion bill in the Senate, and both bills will be reviewed in the coming months.
This article originally appeared on Amarillo Globe-News: Texas bills filed on Panhandle-Plains Historical Museum Management
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
5 hours ago
- Forbes
Republican-Led House Committee Passes Bill To Ban Hemp Products With THC
Delta-8, which contains tetrahydrocannabinol, which the FDA says has not been evaluated or approved ... More "for safe use and may be marketed in ways that put the public health at risk," according to the federal government website, is being marketed in the mid-Atlantic area, including in stores like this one in downtown Baltimore on May 12, 2022. (Karl Merton Ferron/Baltimore Sun/Tribune News Service via Getty Images) A Republican-led House committee has approved a spending bill that includes a measure to ban all hemp products with THC nationwide, a move that could upend the entire U.S. hemp industry. The House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies approved on June 5 the fiscal year 2026 spending proposal in a 9–7 vote, sending it to the full Committee. The bill covers a wide range of issues, including hemp. One section of the bill would, in fact, redefine hemp under federal law to ban cannabis products that contain any 'quantifiable' amount of THC or any other cannabinoids with similar effects or marketed as such on people or animals. The language used to define hemp is similar to an amendment to the new Farm Bill that was approved last year by the U.S. House Agriculture Committee. That amendment, proposed by Republican Rep. Mary Miller of Illinois, aimed to shut down the gray market for intoxicating hemp-derived products like delta-8 THC by closing the loophole created by the 2018 Farm Bill. However, it wasn't ultimately enacted by the last Congress. Still, the goal remains the same: to close the hemp loophole that's led to a flood of unregulated, intoxicating products being sold online and at gas stations nationwide, as emphasized by the Committee's press release. Specifically, the bill would redefine hemp to exclude any finished hemp products that contain cannabinoids not naturally produced by the plant, cannabinoids that are naturally occurring but were made or altered outside the plant, any quantifiable amount of THC or THCA, or other cannabinoids with similar effects on people or animals. It would also give the U.S. Secretary of Health and Human Services the authority to decide what counts as a 'quantifiable amount' of THC or similar cannabinoids. At the same time, industrial hemp grown for industrial purposes would be treated differently, signaling a significant change to the current hemp definition, which, under the 2018 Farm Bill, meant plants with no more than 0.3% THC by dry weight before harvest. Paula Savchenko, Esq., founding partner of Cannacore Group and PS Law Group, said that the proposed legislation, while maintaining the legal status of industrial hemp for purposes such as fiber, grain, and certain edible products intended for human consumption, 'would effectively ban the vast majority of hemp-derived cannabinoids,' adding that 'its future will depend on further deliberations in Congress and potential revisions during the legislative process.' The bill is now set for discussion and possible amendments before the full House Appropriations Committee on June 11. Hemp was legalized nationwide in 2018 with the Farm Bill, which set a limit of 0.3% THC for cannabis grown for industrial purposes. This was meant to keep hemp products from having the intoxicating effects of recreational cannabis, which remains illegal at the federal level. But the rise of hemp cannabinoid extraction opened the door to products containing intoxicating hemp-derived cannabinoids like delta-8 THC, which users say produces a similar high to traditional cannabis. These products are now widely sold in stores, gas stations, and online across the country. A 2022 study found they're especially popular in states that haven't legalized recreational cannabis. The gray legal status of hemp products with THC has stirred concern over both safety and regulation. Though technically legal under federal law, their effects closely mirror those of recreational cannabis, which is still banned at the federal level. That disconnect has left states scrambling, as businesses capitalize on a loophole in the Farm Bill to produce and sell these products with little oversight. The boom of hemp products with THC has, in fact, fueled what's expected to become a multi-billion dollar industry. But it has also pushed many states to step in with their own rules, some opting to regulate, others choosing outright bans. States like Minnesota, Iowa, and Kentucky have regulated products like delta-8 THC, while New York, Delaware, and Colorado, among other states, have banned them altogether. In recent months, Texas lawmakers have been trying to ban hemp products with THC. While states continue crafting their own rules on hemp products with THC, this federal bill could shut the entire market down by banning all such products nationwide and closing the loophole that allowed hemp products with THC to be sold legally under the 2018 Farm Bill. The move, however, has sparked a backlash from hemp industry associations. Jonathan Miller, general counsel for the U.S. Hemp Roundtable, said in a press statement that the group is 'deeply disappointed' with Rep. Andy Harris, Republican of Maryland, who chairs the House Agriculture Appropriations Subcommittee. Miller accused Harris of trying to 'shoehorn a farmer-crushing, job-killing hemp ban into a spending bill,' and expressed hope that the effort will fail, as it has in the past. Meanwhile, the National Cannabis Industry Association (NCIA) is calling on lawmakers to reject proposed language that would redefine hemp in a way that bans any product with a 'quantifiable' amount of THC. The group warns that the ban on hemp products with THC would devastate legal businesses and drive demand toward the unregulated black market.
Newsweek
10 hours ago
- Newsweek
Marijuana Bill Could See Edibles Outlawed in US: What to Know
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A Republican-controlled House subcommittee has voted to back a bill that makes most hemp-derived cannabinoid products, including edibles, illegal at the federal level. On Thursday, the House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies endorsed the 138-page bill in a 9-7 vote. Newsweek contacted Republican Representative Andy Harris of Maryland, the subcommittee's chair, for comment on Friday via email outside regular office hours. Why It Matters During the first Trump administration, the 2018 Farm Bill legalized hemp—a weaker form of cannabis containing a maximum of 0.3 percent tetrahydrocannabinol (THC)—on the federal level. Hemp production exploded by 445 percent in the first year, according to the advocacy group Vote Hemp. If passed, the subcommittee-backed bill would largely reverse this move, which one hemp company said would "destroy the entire American hemp industry." Products containing full spectrum cannabidiol from R and R Medicinals on the shelf of a boutique retail store in Denver on August 9, 2020. Products containing full spectrum cannabidiol from R and R Medicinals on the shelf of a boutique retail store in Denver on August 9, 2020. Smith Collection/Gado/GETTY What To Know The bill would redefine hemp to prohibit any product containing "quantifiable" levels of THC or tetrahydrocannabinolic acid, a precursor to THC. It would also ban cannabinoids that have effects "similar to THC" or are marketed as such, with exemptions for FDA-approved medications such as Epidiolex. Hemp's federal legalization would apply to products such as grains, oil, nuts, fiber and some edible leaves but not cannabinoid products. Under current law, hemp products are allowed as long as they don't contain more than 0.3 percent THC by dry weight. A similar measure was attached to the 2024 Farm Bill following an amendment from Republican Representative Mary Miller of Illinois, but it was not passed into law. In November, voters in Nebraska supported the legalization of medical marijuana, while an attempt to legalize marijuana for recreational use failed to reach the 60 percent threshold in Florida. The following month, Texas Lieutenant Governor Dan Patrick endorsed a bill introduced to the state Legislature banning the sale of "all forms of consumable Tetrahydrocannabinol." What People Are Saying The House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies said in a statement: "[The bill] supports the Trump Administration and mandate of the American people by … closing the hemp loophole that has resulted in the proliferation of unregulated intoxicating hemp products, including Delta-8 and hemp flower, being sold online and in gas stations across the country." Jim Higdon, a co-founder of Cornbread Hemp, told the publication Marijuana Movement: "If this amendment becomes law, it will destroy the entire American hemp industry and set back a decade's worth of progress to fully legalize cannabis. Democrats and Republicans who believe in freedom should oppose Representative Harris' attack on American hemp farmers." Aaron Smith, the CEO of the National Cannabis Industry Association, said in a news release: "Hemp-derived THC products are already widely available across the country. Despite legislators' intent, this budget provision won't change that fact, but it will ensure these products are made and sold without oversight, delivering a big win to the drug cartels at the expense of public health and safety. "Congress should empower federal agencies to regulate these products responsibly, not double down on prohibitionist policies that have already proven to be failures both in practice and in the court of public opinion." Wine and Spirits Wholesalers of America, which described the bill as "overly broad" and "troublesome," said in an email to supporters: "In the absence of a robust federal regulatory system, states have been filling the void by passing comprehensive legislation to regulate intoxicating hemp and protect public health and safety within their borders. … Adoption of the current language contained in this bill would undermine those state actions and do nothing to eliminate bad actors who irresponsibly market potentially harmful products." What Happens Next It is unclear what attitude the Trump administration will take toward the proposed legislation. A similar measure pursued by a Republican lawmaker in 2024 was not passed into law.
Yahoo
12 hours ago
- Yahoo
Texas reined in recreational THC for more medical marijuana this legislative session
Texas lawmakers this year heavily focused their drug policy agenda on banning tetrahydrocannabinol, or THC, products in the state. Senate Bill 3, which prohibits the possession of consumable hemp products that contain any synthetic cannabinoid, often known as delta-8, was a priority for Lt. Gov. Dan Patrick, who often denounced the effects of the drug on children. As a concession of sorts to veterans and THC users with chronic conditions, House Bill 46 also passed, expanding the state's medical marijuana program by providing more products to users and adding more qualifying conditions. Both bills found themselves tied together as lawmakers reasoned that removing hemp options from the general public could be offset by expanding the medical marijuana industry. While the focus was primarily on THC this session, Texas quietly passed Senate Bill 2308, which would create a state-funded consortium to research a psychedelic drug called ibogaine. The clinical trials would test whether ibogaine is a viable treatment for substance use disorders and other mental health conditions. However, multiple bills that could have prevented overdose deaths failed to gain traction this year. House Bill 1644, for example, would have removed testing strips for fentanyl and xylazine, a veterinary sedative also known as 'tranq,' from the list of banned drug paraphernalia. In 2019, Texas lawmakers embraced the potential to boost the state's agricultural market by legalizing hemp products derived from cannabis plants with less than 0.3% of THC. Six years later, SB 3 intends to shut down the $8 billion hemp industry and cut its estimated 50,000 jobs when the ban takes effect in September. Critics say the hemp industry has exploited a loophole in the 2019 law to the tune of more than 8,000 retailers now selling THC-laced edibles, drinks, vapes, and flower buds. The proposed law would ban consumable hemp products that contain any synthetic cannabinoid, often known as delta-8. Non-intoxicating and non-psychoactive CBD or CBG would remain legal. People found in possession of a product with those intoxicating cannabis compounds could face a fine of up to $500. Higher fines and jail time would be possible for repeat offenders. Hemp industry leaders and advocates have denied any harmful intentions and are in favor of regulations on the industry rather than a ban. Aging Texans, veterans, and parents of children with mental illness or special needs have spoken out about the benefits of hemp, including the ease of access, the variety of products available to them, and the lower price. In contrast, concerned parents demanded a ban because they fear children would be harmed from recreational use. The Texas Hemp Business Council reported that it delivered 5,000 letters to Abbott's office earlier this week, along with a petition signed by over 120,000 people, urging the governor to veto the bill. Abbott has until June 22 to decide on a veto. In Texas, licensed medical cannabis providers must house all operations — including cannabis cultivation, processing, extracting, manufacturing, testing, and dispensing — under one roof. State regulations also prohibit inventory storage of medical cannabis products in multiple locations, so products must be distributed from the central dispensary. Any prescriptions scheduled for pickup outside the central dispensary must be driven daily to and from the pickup location — sometimes hundreds of miles round-trip. This has made their products more expensive and limited where the medical marijuana program can reach, hampering the small medical cannabis market in Texas. HB 46 aims to help by expanding the program to include more popular products such as prescribed inhalers and vaping devices, allow off-site storage and add nine dispensers, bringing the total to 12. It also adds traumatic brain injuries, chronic pain, Crohn's disease, and terminal illnesses to the list of qualifying conditions. The first three dispensers will be selected from the previously submitted 2015 list of dispensers and then made available to the public. The expansion of the medical marijuana program will go into effect in September if Abbott signs it into law. Among drug-related bills that received less attention was SB 2308, which will make Texas a hub for ibogaine-related research, development, treatment, manufacturing, and distribution. This will be accomplished by creating a consortium that includes higher education institutions, drug developers, nonprofits, and other stakeholders to secure U.S. Food and Drug Administration approval for a treatment. Ibogaine is a psychedelic found in the roots of the iboga plant, primarily found in Africa, and has been used for centuries during shamanistic rituals due to its ability to induce hallucinations in large doses. The drug has been illegal in many countries, but scientists recently announced a study finding that, in low doses, ibogaine might have beneficial uses to treat addiction, PTSD, and brain injuries. The bill could essentially give Texas a stake in any future revenue that may come from the state developing a medical use for ibogaine. The program will be funded through a $50 million appropriation from the state's general fund. Fentanyl, a potent drug commonly mixed with other substances and has caused the deaths of more than 7,000 Texans in the last six years, is odorless and tasteless, making detection nearly impossible without specialized equipment. Fentanyl test strips are among the cheapest and easiest ways to prevent overdoses, but for a third time, legislation to legalize them failed in the Senate. HB 1644, which would have legalized opioid drug testing strips, never got a hearing in the Senate despite passing unanimously in the House. The main argument against drug testing strips has been that it encourages continued drug use, but advocates deny this claim, saying that once someone is thinking about their safety, it is by the time they are getting close to quitting. Senate Bill 1732, which would have allowed nurses and physician assistants to prescribe medication-assisted treatment, like methadone and buprenorphine, for opioid use disorders, also never received a committee hearing. A smaller step lawmakers made to address overdoses comes in House Bill 4783, which requires the Texas Health and Human Services Commission to prepare a report every two years for lawmakers to evaluate the distribution of opioid overdose reversal drugs, like Narcan. The report will be required to create a statewide goal for opioid reversal drugs and include an estimate of insufficiencies in the current supply and a plan to address overdoses in high-risk areas.
